Global X Genomics & Biotechnology ETF
GNOM
6 hedge funds and large institutions have $9.83M invested in Global X Genomics & Biotechnology ETF in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
2,270% more capital invested
Capital invested by funds: $415K → $9.83M (+$9.42M)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
66.01% more ownership
Funds ownership: 2.33% → 68.34% (+66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$10.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$328K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$130K |
| 4 |
AA
Advisory Alpha
Holland,
Michigan
|
+$25.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$381K |
GNOM Hedge Fund Activity: Q3 2019 in Review
6 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2019, worth a combined $9.83M — up 2,270% from $415K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GNOM positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $10.6M. The largest seller was Jane Street, exiting entirely with an estimated $381K sold.
- 6 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2019, up from 3 in Q2 2019.
- Funds reported $9.83M of Global X Genomics & Biotechnology ETF stock for Q3 2019, up 2,270% quarter-over-quarter.
- 4 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2019 and 1 closed out, a net change of +3 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2019 was Citigroup, an estimated $10.6M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2019 was Jane Street, an estimated $381K sold.
Based on aggregated 13F filings for Q3 2019.